Pneumocystis Primary Infection in Non-immunosuppressed Infants

NCT03740646 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-09-08

No results posted yet for this study

Summary

To determine the prevalence of P. jirovecii in nasopharyngeal aspirations of neonates and infants hospitalized for symptomatic respiratory infection.

Conditions

  • Pulmonary Diseases
  • Fever

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • NEVEZ Gilles, MD PhD · Brest University Hospital, Brest, France

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03740646 on ClinicalTrials.gov